BERLIN, GERMANY: Visit DRG's booth 46 at Bio-Europe Fall 2017 to find out how we help healthcare companies make informed, confident decisions in less time with primary market research, timely insights, and analyst support.
Assess the market with DRG Disease Analysis and Forecasting
- Learn the complete story of a disease - from pathways to patient management
- Track the current and projected use of branded, generic or biosimilar drugs
- Evaluate the risks, opportunities and strategies underlying biosimilar development
- Learn how corporate strategies advance branded, generic and biosimilar drugs
Learn how DRG can give you the edge with expert insights powered by primary market research, real world data, and disease-focused analysts.
If you would like to learn more, please schedule a meeting with someone from our team please using the Bio-Europe Partnering Tool.
We look forward to seeing you in Berlin!
Content you may be interested in:
Innovative Contracting: What Europe is Teaching the World
Trends in the Biosimilars Market